Drugs / brimonidine/timolol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02623023 | Jan 2019 | ocular hypertension | McMaster University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brimonidine/timolol | “brimonidine/timolol fixed combination (Combigan®, Allergan; Dublin, IRL)” NCT02623023 ↗ |